Patents by Inventor Yves Guminski

Yves Guminski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110021791
    Abstract: The invention relates to a method for synthesizing 4?-amino-4?-demethyl-4-desoxypodophyllotoxin of formula (1), characterized by comprising the following successive steps: a) reacting, in a pure weak acid or in a mixture consisting of acid, water and of organic solvent, without another solvent, at a temperature higher than the ambient temperature, thiourea with 4?-halogenoacetamido-4?-demethyl-4-desoxypodophyllotoxin, and; b) recovering the 4?-amino-4?-demethyl-4-desoxypodophyllotoxin.
    Type: Application
    Filed: September 30, 2010
    Publication date: January 27, 2011
    Inventors: Yves Guminski, Martial Grousseaud, Thierry Imbert
  • Patent number: 7846926
    Abstract: The present invention relates to novel podophyllotoxin derivatives substituted in the 4-position by a substituted (poly)aminoalkylaminoacetamide chain, to their process of preparation and to their use as medicament as anticancer agents.
    Type: Grant
    Filed: April 14, 2005
    Date of Patent: December 7, 2010
    Assignee: Pierre Fabre Medicament
    Inventors: Thierry Imbert, Yves Guminski, Jean-Marc Barret, Anna Kruczynski
  • Publication number: 20100280263
    Abstract: The present invention describes a new process for the preparation of (poly)aminoalkylaminoacetamide compounds of epipodophyllotoxin useful for their applications in therapeutics as anticancer agents. This process comprises a step of condensation of a primary-amine-containing reactant, whose amine functions are not protected, with ?-chloroacetamido-4?-epipodophyllotoxin in a polar aprotic organic solvent.
    Type: Application
    Filed: September 23, 2008
    Publication date: November 4, 2010
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Yves Guminski, Martial Grousseaud, Thierry Imbert
  • Publication number: 20100202975
    Abstract: The invention relates to novel fluorescent derivatives of polyamines having a benzoxadiazole group, to a method for preparing the same and to the use thereof as diagnosis tools for emphasising the polyamine transport system in cancerous cells in order to adapt the treatment thereof, and thus for selecting patients carrying such tumours in order to adapt their treatment. The derivatives are of the formula (I) or a pharmaceutically acceptable salt thereof, in which: R1 is one or more NO2 groups in position 4 or 6, or a SO2Ph, SO2NMe2, SO2NH2 or SO3H group; R2 is hydrogen, C1-6 alkyl, benzyl, a perfluoroalkyl group; the values of a, b, c range from 2 to 5 independently from each other and represent alkylene chains separating the amino groups, and the values of d and e can independently be 0 or 1.
    Type: Application
    Filed: July 28, 2008
    Publication date: August 12, 2010
    Applicant: Pierre Fabre Medicament
    Inventors: Jean-Philippe Annereau, Jean-Marc Barret, Yves Guminski, Thierry Imbert
  • Publication number: 20090170843
    Abstract: The present invention relates to novel podophyllotoxin derivatives substituted in the 4-position by a substituted (poly)aminoalkylaminoacetamide chain, to their process of preparation and to their use as medicament as anticancer agents.
    Type: Application
    Filed: April 14, 2005
    Publication date: July 2, 2009
    Inventors: Thierry Imbert, Yves Guminski, Jean-Marc Barret, Anna Kruczynski
  • Publication number: 20090137826
    Abstract: The invention relates to a method for synthesizing 4?-amino-4?-demethyl-4-desoxypodophyllotoxin of formula (1), characterized by comprising the following successive steps: a) reacting, in a pure weak acid or in a mixture consisting of acid, water and of organic solvent, without another solvent, at a temperature higher than the ambient temperature, thiourea with 4?-halogenoacetamido-4?-demethyl-4-desoxypodophyllotoxin, and; b) recovering the 4?-amino-4?-demethyl-4-desoxypodophyllotoxin.
    Type: Application
    Filed: July 19, 2006
    Publication date: May 28, 2009
    Inventors: Yves Guminski, Martial Grousseaud, Thierry Imbert
  • Publication number: 20070042971
    Abstract: The invention relates to a crystalline compound of 4?-demethyl-4?-phosphate-2?,3?-bispentafluorophenoxyacetyl-4?,6?-ethylidene-?-D-epipodophyllotoxin glucoside in its free form or solvated with ethanol, advantageously provided in the form of a hemiethanolate solvate. The invention also relates to a method for preparing these compounds and to their use as an anticancer drug.
    Type: Application
    Filed: September 16, 2004
    Publication date: February 22, 2007
    Applicant: Pierre Fabre Medicament
    Inventors: Yves Guminski, Thierry Imbert, Anna Kruczynski
  • Patent number: 6107284
    Abstract: Water-soluble derivatives of epipodophyllotoxin, process for their preparation and their use for the treatment of rheumatoid arthritis, complaints caused by human papilloma virus and cancer.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: August 22, 2000
    Assignee: Pierre Fabre Medicament
    Inventors: Thierry Imbert, Yves Guminski, Barbara Monse, Bridget Hill, Jean-Pierre Robin
  • Patent number: 6008382
    Abstract: A method for synthesizing a 4'-demethylepipodophyllotoxin of formula (II) from a podophyllotoxin of formula (I) by treating it with a pair of reagents, i.e. a strong acid and an aliphatic, aromatic or functionalized sulphide, in the present of an organic or inorganic acid, or in the presence of water with or without a water-miscible organic solvent.
    Type: Grant
    Filed: June 12, 1998
    Date of Patent: December 28, 1999
    Assignee: Pierre Fabre Medicament
    Inventors: Thierry Imbert, Yves Guminski
  • Patent number: 5663173
    Abstract: An optically active isomer or a racemate of a compound of general formula (I) ##STR1## in which either R.sub.1 represents a methoxy or cyclopropylmethoxy group andR.sub.2 represents a hydrogen, chlorine or bromine atom, orR.sub.1 and R.sub.2 together form, and in this order, a group of formula --O--CH.sub.2 --O--, --O--(CH.sub.2).sub.2 --, --O--(CH.sub.2).sub.2 --O-- or --O--(CH.sub.2).sub.3 --O--,R.sub.3 represents a hydrogen atom or an amino group, andR.sub.4 represents a hydrogen, chlorine or bromine atom,in the form of a free base or of a pharmaceutically acceptable acid addition salt.
    Type: Grant
    Filed: June 12, 1996
    Date of Patent: September 2, 1997
    Assignee: Synthelabo
    Inventors: Samir Jegham, Jean Jacques Koenig, Alistair Lochead, Alain Nedelec, Yves Guminski